Artificial Lung Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Artificial Lung is a prosthetic device works as an alternative to the biological lung. It provides oxygenation of blood and removal of carbon dioxide from the blood. GlobalData's Medical Devices sector report, “Artificial Lung – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Artificial Lung pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Artificial Lung Pipeline Landscape report provides key information and data related to:
Extensive coverage of the Artificial Lung under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Artificial Lung pipeline products.
Review of Recent Developments in the segment / industry
The Artificial Lung Pipeline Landscape report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Glaucoma Drainage Device sunder development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
The major companies covered in the “Artificial Lung – Medical Devices Pipeline Product Landscape, 2021” report:
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

Extensive coverage of the Artificial Lung under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Artificial Lung and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Artificial Lung under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product’s current stage of development, territory and estimated launch date

ALung Technologies Inc
Belluscura Limited
Breethe
Inc.
Case Western Reserve University
enmodes GmbH
Lung Biotechnology PBC
MC3 Inc
McGowan Institute for Regenerative Medicine
Miromatrix Medical Inc
The Charles Stark Draper Laboratory Inc
U.S. Ann Arbor Healthcare System
University of Pittsburgh
Veterans Health Administration

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Artificial Lung Overview

3 Products under Development

3.1 Artificial Lung – Pipeline Products by Stage of Development

3.2 Artificial Lung – Pipeline Products by Territory

3.3 Artificial Lung – Pipeline Products by Regulatory Path

3.4 Artificial Lung – Pipeline Products by Estimated Approval Date

4 Artificial Lung – Pipeline Products under Development by Companies

4.1 Artificial Lung Companies – Pipeline Products by Stage of Development

4.2 Artificial Lung – Pipeline Products by Stage of Development

5 Artificial Lung Companies and Product Overview

5.1 ALung Technologies Inc Company Overview

5.1.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Belluscura Limited Company Overview

5.2.1 Belluscura Limited Pipeline Products & Ongoing Clinical Trials Overview

5.3 Breethe, Inc. Company Overview

5.3.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.4 Case Western Reserve University Company Overview

5.4.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview

5.5 enmodes GmbH Company Overview

5.5.1 enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.6 Lung Biotechnology PBC Company Overview

5.6.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview

5.7 MC3 Inc Company Overview

5.7.1 MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 McGowan Institute for Regenerative Medicine Company Overview

5.8.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.9 Miromatrix Medical Inc Company Overview

5.9.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 The Charles Stark Draper Laboratory Inc Company Overview

5.10.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 U.S. Ann Arbor Healthcare System Company Overview

5.11.1 U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview

5.12 University of Pittsburgh Company Overview

5.12.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

5.13 Veterans Health Administration Company Overview

5.13.1 Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview

6 Artificial Lung- Recent Developments

6.1 Apr 14, 2020: OnScale launches project BreathEasy: digital twins of lungs to improve COVID-19 patients outcomes

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

List of Tables

Artificial Lung – Pipeline Products by Stage of Development

Artificial Lung – Pipeline Products by Territory

Artificial Lung – Pipeline Products by Regulatory Path

Artificial Lung – Pipeline Products by Estimated Approval Date

Artificial Lung Companies – Pipeline Products by Stage of Development

Artificial Lung – Pipeline Products by Stage of Development

ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Next Generation Artificial Lung – Product Status

Next Generation Artificial Lung – Product Description

Belluscura Limited Pipeline Products & Ongoing Clinical Trials Overview

Portable Artificial Lung – Product Status

Portable Artificial Lung – Product Description

Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Abiomed Breethe OXY-1 System – Product Status

Abiomed Breethe OXY-1 System – Product Description

Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview

Portable Artificial Lung – Product Status

Portable Artificial Lung – Product Description

enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview

RAS-Q – Product Status

RAS-Q – Product Description

Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview

3D Bioprinted Lung Transplant – Product Status

3D Bioprinted Lung Transplant – Product Description

XenoLung – Product Status

XenoLung – Product Description

MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview

BioLung – Product Status

BioLung – Product Description

McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview

A – modELAS – Product Status

A – modELAS – Product Description

A,P- modELAS – Product Status

A,P- modELAS – Product Description

Chronic Artificial Lung – Product Status

Chronic Artificial Lung – Product Description

P- modELAS – Product Status

P- modELAS – Product Description

Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Mirolung – Product Status

Mirolung – Product Description

The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview

Silicone-Based Microfluidic Artificial Lung – Product Status

Silicone-Based Microfluidic Artificial Lung – Product Description

U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview

3D-Printed Artificial Lung – Product Status

3D-Printed Artificial Lung – Product Description

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

P-PAL – Product Status

P-PAL – Product Description

Paracorporeal Ambulatory Assist Lung – Product Status

Paracorporeal Ambulatory Assist Lung – Product Description

Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview

Artificial Lung – Product Status

Artificial Lung – Product Description

Glossary

Figures

List of Figures

Artificial Lung – Pipeline Products by Stage of Development

Artificial Lung – Pipeline Products by Territory

Artificial Lung – Pipeline Products by Regulatory Path

Artificial Lung – Pipeline Products by Estimated Approval Date

Frequently asked questions

Artificial Lung Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Artificial Lung Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Artificial Lung Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Artificial Lung Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.